Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL. (Q40612200)
Jump to navigation
Jump to search
scientific article published on September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL. |
scientific article published on September 2003 |
Statements
1 reference
Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL. (English)
1 reference
Mary Collins
1 reference
Krystyna Zuberek
1 reference
Vincent Ling
1 reference
Paul Wu
1 reference
Hak-Ling Ma
1 reference
John P Leonard
1 reference
Kyriaki Dunussi-Joannopoulos
1 reference
1 September 2003
1 reference
1 reference
Identifiers
1 reference